Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers

Clinical Lung Cancer

Volumn 14, Issue 1, 2013, Pages 45-49

  Zhang, Yongjun ^a   Hua, Shi ^a   Zhang, Aiqin ^a   Kong, Xiangming ^a   Jiang, Chuming ^a   Deng, Dehou ^a   Wenlong, Bao ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Chinese population; Non small cell lung cancer; Nonsmokers; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17; CYTOCHROME P450 17A1; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOINOSITIDE SPECIFIC PHOSPHOLIPASE C ETA 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; CHINA; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PHOSPHOINOSITIDE PHOSPHOLIPASE C; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84871598395     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.04.004     Document Type: Article

References (45)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics CA Cancer J Clin 2009 2009 225 249
2. L. Yang, L. Li, D.M. Parkin Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China [in Chinese with English abstract] Zhongguo Fei Ai Zhi 8 2005 274 278
3. A. Jemal, R. Siegel, E. Ward Cancer statistics CA Cancer J Clin 2008 2008 71 96
4. J.R. Molina, P. Yang, S.D. Cassivi Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 2008 584 594
5. A.G. Schwartz, A.S. Wenzlaff, C.H. Bock Admixture mapping of lung cancer in 1812 African-Americans Carcinogenesis 32 2011 312 317
6. M.L. Cote, W. Yoo, A.S. Wenzlaff Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women Carcinogenesis 30 2009 626 635
7. P. Ball, R. Knuppen Catecholoestrogens (2 and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance Acta Endocrinol Suppl (Copenh) 232 1980 1 127
8. S. Colilla, C. Lerman, P.G. Shields Association of catechol-O-methyl- transferase with smoking cessation in two independent studies of women Pharmacogenet Genomics 15 2005 393 398
9. C.P. Martucci, J. Fishman P450 enzymes of estrogen metabolism Pharmacol Ther 57 1993 237 257
10. H.S. Feigelson, L.S. Shames, M.C. Pike Cytochrome P450c17 alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations Cancer Res 58 1998 585 587
11. J. Picado-Leonard, W.L. Miller Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21 DNA 6 1987 439 448
12. G.D. Means, M.S. Mahendroo, C.J. Corbin Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis J Biol Chem 264 1989 19385 19391
13. J.I. Hwang, Y.S. Oh, K.J. Shin Molecular cloning and characterization of a novel phospholipase C, PLC-eta Biochem J 389 2005 181 186
14. N. Frusch, L. Bosquée, R. Louis Lung cancer Epidemiology and etiologic factors Rev Med Liege 62 2007 548 553
15. E. Carbonnelle, C. Mesquita, E. Bille MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory Clin Biochem 44 2011 104 109
16. H.M. Lachman, D.F. Papolos, T. Saito Human catechol-O-methyltransferase pharmaco-genetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250
17. M.A. Palmatier, A.M. Kang, K.K. Kidd Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles Biol Psychiatry 46 1999 557 567
18. S. Dawling, N. Roodi, R.L. Mernaugh Catechol-O-methyltransferase (COMT) mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms Cancer Res 61 2001 6716 6722
19. E.L. Cavalieri, D.E. Stack, P.D. Devanesan Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators Proc Natl Acad Sci U S A 94 1997 10937 10942
20. E.L. Cavalieri, E. Rogan, D. Chakravarti The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases Methods Enzymol 382 2004 293 319
21. K.M. Li, R. Todorovic, P. Devanesan Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo Carcinogenesis 25 2004 289 297
22. D. Chakravarti, P.C. Mailander, K.M. Li Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene Oncogene 20 2001 7945 7953
23. D. Chakravarti, P.C. Mailander, S. Higginbotham The catechol estrogen-3,4-quinone metabolite induces mutations in the mammary gland of ACI rats Proc Am Assoc Cancer Res 44 2003 180
24. J. Russo, M. Hasan Lareef, G. Balogh Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells J Steroid Biochem Mol Biol 87 2003 1 25
25. M.H. Lareef, J. Garber, P.A. Russo The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells Int J Oncol 26 2005 423 429
26. S. Zienolddiny, D. Campa, H. Lind A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers Carcinogenesis 29 2008 1164 1169
27. S. Mollerup, K. Jorgensen, G. Berge Expression of estrogen receptors alpha and deta in human lung tissue and cell lines Lung Cancer 37 2002 153 159
28. W. Tan, J. Qi, Dy Xing Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women [in Chinese with English abstract] Zhonghua Zhong Liu Za Zhi 25 2003 453 456
29. Y. Zhang, C. Gu, H. Shi Association between C3orf21, TP63 polymorphisms and environment and NSCLC in never-smoking Chinese population Gene 497 2012 93 97
30. K. Fukami Structure, regulation, and function of phospholipase C isozymes J Biochem 131 2002 293 299
31. T.F. Martin PI(4,5)P(2) regulation of surface membrane traffic Curr Opin Cell Biol 13 2001 493 499
32. S.G. Rhee Regulation of phosphoinositide-specific phospholipase C Annu Rev Biochem 70 2001 281 312
33. R.F. Irvine Nuclear lipid signalling Nat Rev Mol Cell Biol 4 2003 349 360
34. Y. Ha, A. Tsukada, N. Saito Identification of differentially expressed genes involved in the regression and development of the chicken Müllerian duct Int J Dev Biol 52 2008 1135 1141
35. M. Nakahara, M. Shimozawa, Y. Nakamura A novel phospholipase C, PLC(eta)2, is a neuron-specific isozyme J Biol Chem 280 2005 29128 29134
36. 2+ signalling components in neuronal and neuroendocrine tissues Neuroendocrinology 86 2007 243 248
37. J.K. Kim, J.W. Choi, S. Lim Phospholipase C-η1 is activated by intracellular Ca(2+) mobilization and enhances GPCRs/PLC/Ca(2+) signaling Cell Signal 23 2011 1022 1029
38. J. Qian, P.P. Massion Role of chromosome 3q amplification in lung cancer J Thorac Oncol 3 2008 212 215
39. A.H. Carey, D. Waterworth, K. Patel Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 Hum Mol Genet 3 1994 1873 1876
40. S.H. Olson, E.V. Bandera, I. Orlow Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review Am J Epidemiol 165 2007 235 245
41. O. Cussenot, A.R. Azzouzi, N. Nicolaiew Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens J Clin Oncol 25 2007 3596 3602
42. M.M. Gaudet, J.V. Lacey Jr, J. Lissowska Genetic variation in CYP17 and endometrial cancer risk Hum Genet 123 2008 155 162
43. V.W. Setiawan, F.R. Schumacher, C.A. Haiman CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol Biomarkers Prev 16 2007 2237 2246
44. S.E. Olivo-Marston, L.E. Mechanic, S. Mollerup Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women Carcinogenesis 31 2010 1778 1786
45. D.W. Bell, B.W. Brannigan, K. Matsuo Increased prevalence of EGFR-mutant lung cancer in women and in east Asian populations: analysis of estrogen-related polymorphisms Clin Cancer Res 14 2008 4079 4084